Found: 2

Select item for more details and to access through your institution.

  • Phase II study of sorafenib in patients with relapsed or refractory lymphoma.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 1, p. 108, doi. 10.1111/j.1365-2141.2012.09139.x
    By:
    • Guidetti, Anna;
    • Carlo-Stella, Carmelo;
    • Locatelli, Silvia L.;
    • Malorni, Walter;
    • Pierdominici, Marina;
    • Barbati, Cristiana;
    • Mortarini, Roberta;
    • Devizzi, Lilli;
    • Matteucci, Paola;
    • Marchianò, Alfonso;
    • Lanocita, Rodolfo;
    • Farina, Lucia;
    • Dodero, Anna;
    • Tarella, Corrado;
    • Di Nicola, Massimo;
    • Corradini, Paolo;
    • Anichini, Andrea;
    • Gianni, Alessandro M.
    Publication type:
    Article

  • Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.

    Published in:
    Cancer (0008543X), 2011, v. 117, n. 22, p. 5074, doi. 10.1002/cncr.26182
    By:
    • Guidetti, Anna;
    • Carlo-Stella, Carmelo;
    • Ruella, Marco;
    • Miceli, Rosalba;
    • Devizzi, Lilli;
    • Locatelli, Silvia L.;
    • Giacomini, Arianna;
    • Testi, Adele;
    • Buttiglieri, Stefano;
    • Risso, Alessandra;
    • Mariani, Luigi;
    • Di Nicola, Massimo;
    • Passera, Roberto;
    • Tarella, Corrado;
    • Gianni, Alessandro M.
    Publication type:
    Article